This translation has been automatically generated and has not been verified for accuracy.A person grabs a syringe from a cooler at a COVID-19 vaccine drive-thru clinic at Richardson Stadium in Kingston, Ont., on May 28, 2021. Calgary-based Providence Therapeutics says it has signed two contracts to have its developmental mRNA vaccine made in Canada.
A Phase 2 clinical trial in 525 people is now about to begin to further test the safety and effectiveness of the vaccine. Canada’s lacklustre manufacturing capacity for vaccines was a major issue heading into the COVID-19 vaccination procurement process and the federal government is working to expand the industry.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше: